# Impact of Hepatitis C Virus Therapy on Central Nervous System Outcomes

> **NCT02650024** · — · COMPLETED · sponsor: **University of California, San Diego** · enrollment: 16 (actual)

## Conditions studied

- Hepatitis C
- Human Immunodeficiency Virus

## Interventions

_None listed._

## Key facts

- **NCT ID:** NCT02650024
- **Lead sponsor:** University of California, San Diego
- **Sponsor class:** OTHER
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** COMPLETED
- **Start date:** 2016-01
- **Primary completion:** 2021-04
- **Final completion:** 2021-04
- **Target enrollment:** 16 (ACTUAL)
- **Last updated:** 2021-04-27


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT02650024

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT02650024, "Impact of Hepatitis C Virus Therapy on Central Nervous System Outcomes". Retrieved via AI Analytics 2026-07-17 from https://api.ai-analytics.org/clinical/NCT02650024. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*